Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rorer International Overseas Inc
Original Assignee
Rorer International Overseas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer International Overseas IncfiledCriticalRorer International Overseas Inc
Priority to ES539269ApriorityCriticalpatent/ES539269A0/es
Publication of ES8601939A1publicationCriticalpatent/ES8601939A1/es
Publication of ES539269A0publicationCriticalpatent/ES539269A0/es
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE BENZOISOTIAZOL, DE FORMULA (I), EN LA QUE X Y R1 PUEDEN SER VARIOS TIPOS DE RADICALES Y A VALE 0-2; B Y D 0 O 1; E 2-4; Y C ES 1-B, 2-B O 3-B. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), CON 3-CLOROBENZOISOTIAZOL-1, 1-DIOXIDO. LA REACCION DE CONDENSACION SE LLEVA A CABO SIGUIENDO METODOS CONVENCIONALES. EL PRODUCTO OBTENIDO SE SEPARA POR FILTRACION Y SE PURIFICA MEDIANTE RECRISTALIZACION. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE HIPERACIDEZ GASTROINTESTIONAL Y TRASTORNOS ULCEROGENOS.
ES539269A1984-12-311984-12-31Un procedimiento para la preparacion de derivados de benzoisotiazol
GrantedES539269A0
(es)
Pyrazolo (3,4-c) and thiazolo (5,4-c) isoquinolines, methods for preparing them, these compounds for use as antiinflammatory, cns-depressant and anti-anxiety agents and pharmaceutical compositions thereof
Aminoacyl derivatives of 4,9-dihydro-10h-pyridoû3,2-b¨-thieno-û3,2-e¨û1,4¨diazepinone and of 4,9-dihydro-10h-pyridoû3,2-b¨-thienoû3,4-e¨û1,4¨diazepinone, their preparation and pharmaceutical compositions containing them